BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30659902)

  • 1. Ex-vivo Imaging of Upper Tract Urothelial Carcinoma Using Novel pH Low Insertion Peptide (Variant 3), a Molecular Imaging Probe.
    Brito J; Golijanin B; Kott O; Moshnikova A; Mueller-Leonhard C; Gershman B; Andreev OA; Reshetnyak YK; Amin A; Golijanin D
    Urology; 2020 May; 139():134-140. PubMed ID: 30659902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted imaging of urothelium carcinoma in human bladders by an ICG pHLIP peptide ex vivo.
    Golijanin J; Amin A; Moshnikova A; Brito JM; Tran TY; Adochite RC; Andreev GO; Crawford T; Engelman DM; Andreev OA; Reshetnyak YK; Golijanin D
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11829-11834. PubMed ID: 27688767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Bladder Urothelial Carcinoma with pHLIP-ICG and Inhibition of Urothelial Cancer Cell Proliferation by pHLIP-amanitin.
    Moshnikova A; Golijanin B; Amin A; Doyle J; Kott O; Gershman B; DuPont M; Li Y; Lu X; Engelman DM; Andreev OA; Reshetnyak YK; Golijanin D
    Front Urol; 2022; 2():. PubMed ID: 36439552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical Coherence Tomography as a Tool for In Vivo Staging and Grading of Upper Urinary Tract Urothelial Carcinoma: A Study of Diagnostic Accuracy.
    Bus MT; de Bruin DM; Faber DJ; Kamphuis GM; Zondervan PJ; Laguna-Pes MP; van Leeuwen TG; de Reijke TM; de la Rosette JJ
    J Urol; 2016 Dec; 196(6):1749-1755. PubMed ID: 27475968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis predicts poor clinical outcomes in patients with node-negative upper urinary tract urothelial carcinoma.
    Zhang XK; Zhang ZL; Yang P; Cai MY; Hu WM; Yun JP; Zhou FJ; Qian CN; Cao Y
    Jpn J Clin Oncol; 2015 Nov; 45(11):1069-75. PubMed ID: 26355163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vivo Distribution and Therapeutic Efficacy of Radioiodine-Labeled pH-Low Insertion Peptide Variant 3 in a Mouse Model of Breast Cancer.
    Zhang M; Xi Y; Chen H; Hai W; Li B
    Mol Imaging; 2022; 2022():7456365. PubMed ID: 35903249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Near-Infrared Fluorescence Imaging of Atherosclerosis: Clinical and Intracoronary Evaluation of Indocyanine Green.
    Verjans JW; Osborn EA; Ughi GJ; Calfon Press MA; Hamidi E; Antoniadis AP; Papafaklis MI; Conrad MF; Libby P; Stone PH; Cambria RP; Tearney GJ; Jaffer FA
    JACC Cardiovasc Imaging; 2016 Sep; 9(9):1087-1095. PubMed ID: 27544892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near infrared fluorescence imaging system for laparoscopic partial nephrectomy.
    Yamasaki T; Tamada S; Kato M; Otoshi T; Tanaka H; Iguchi T; Nakatani T
    Can J Urol; 2018 Dec; 25(6):9606-9613. PubMed ID: 30553287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pH low insertion peptide pHLIP Variant 3 as a novel marker of acidic malignant lesions.
    Tapmeier TT; Moshnikova A; Beech J; Allen D; Kinchesh P; Smart S; Harris A; McIntyre A; Engelman DM; Andreev OA; Reshetnyak YK; Muschel RJ
    Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9710-5. PubMed ID: 26195776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Near-infrared fluorescence imaging with intraoperative administration of indocyanine green for robotic partial nephrectomy.
    Bjurlin MA; McClintock TR; Stifelman MD
    Curr Urol Rep; 2015 Apr; 16(4):20. PubMed ID: 25698588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near infrared fluorescence imaging after intravenous indocyanine green: initial clinical experience with open partial nephrectomy for renal cortical tumors.
    Tobis S; Knopf JK; Silvers CR; Marshall J; Cardin A; Wood RW; Reeder JE; Erturk E; Madeb R; Yao J; Singer EA; Rashid H; Wu G; Messing E; Golijanin D
    Urology; 2012 Apr; 79(4):958-64. PubMed ID: 22336035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volumetric in vivo visualization of upper urinary tract tumors using optical coherence tomography: a pilot study.
    Bus MT; Muller BG; de Bruin DM; Faber DJ; Kamphuis GM; van Leeuwen TG; de Reijke TM; de la Rosette JJ
    J Urol; 2013 Dec; 190(6):2236-42. PubMed ID: 23954585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic value of optical imaging combined with indocyanine green-guided sentinel lymph node biopsy in gastric cancer: a meta-analysis].
    He MF; Jiang ZW; Hao ZW; An J; Zhai J; Shen JK
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1196-1204. PubMed ID: 31874538
    [No Abstract]   [Full Text] [Related]  

  • 14. Visualization of endometriosis with laparoscopy and near-infrared optics with indocyanine green.
    Siegenthaler F; Knabben L; Mohr S; Nirgianakis K; Imboden S; Mueller MD
    Acta Obstet Gynecol Scand; 2020 May; 99(5):591-597. PubMed ID: 31943126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confocal laser endomicroscopy of bladder and upper tract urothelial carcinoma: a new era of optical diagnosis?
    Chen SP; Liao JC
    Curr Urol Rep; 2014 Sep; 15(9):437. PubMed ID: 25002073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of near infrared fluorescence tumor localization during robotic partial nephrectomy.
    Angell JE; Khemees TA; Abaza R
    J Urol; 2013 Nov; 190(5):1668-73. PubMed ID: 23643597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
    Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
    J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urinary cytology in the diagnosis of upper urinary tract urothelial tumor].
    González-Peramato P; Jiménez-Heffernan JA; García-González R; García-Navas R
    Arch Esp Urol; 2004 Apr; 57(3):227-38. PubMed ID: 15174501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive voided urine cytology predicts worse pathological findings of nephroureterectomy specimens in patients with upper tract urothelial carcinoma: does selective ureteral cytology have an additional efficacy?
    Sakano S; Inamoto T; Inoue R; Matsumoto H; Nagao K; Yamamoto Y; Azuma H; Matsuyama H
    Jpn J Clin Oncol; 2015 Oct; 45(10):968-72. PubMed ID: 26232447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinoma.
    Simon CT; Skala SL; Weizer AZ; Ambani SN; Chinnaiyan AM; Palapattu G; Hafez K; Magers MJ; Kaffenberger SD; Spratt DE; Montgomery JS; Morgan TM; Udager AM; Lew M; Mehra R
    Hum Pathol; 2019 Apr; 86():76-84. PubMed ID: 30537495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.